The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.
Roland Holland(Radboud University Nijmegen), Jeffrey R. Harris(Harvard University), André L. M. Verbeek(Radboud University Nijmegen), Rebecca Gelman(Dana-Farber Cancer Institute), John Boyages(Australian Cancer Research Foundation), S J Schnitt, Jan H. C. L. Hendriks(University of Antwerp), Barbara Silver(Brigham and Women's Hospital), James L. Connolly(Beth Israel Deaconess Medical Center), M Mravunac
Cited by 461
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|988
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
|Journal of Clinical Oncology|2010|983